Novel 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinoline-5-yl Amine Compounds as 5‑HT2C Agonists for Treating Psychotic Disorders, Namely, Personality Disorders and Eating Disorders.

Provided herein are novel 5,6-dihydro-4H-pyrrolo-[3,2,1-ij]-quinoline-5-yl amine compounds as 5-HT2C agonists, pharmaceutical compositions, use of such compounds in treating psychotic disorders, namely, personality disorders and eating disorders, and processes for preparing such compounds.